Evidence map›Paper›PMID 36176865›Full record

ReviewCureus2022

Myxomatous Liposarcoma of the Mediastinum: A Review of the Literature.

Syed A Bokhari, Shahan Haseeb, Mohammad W Baig, Palwasha Qamar, Hamza H Bangash, Zahra B Manzoor, Haider Ali Babar Khan, Misbah Kaleem, Shafia Munir, Shawal Haseeb

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Syed A BokhariInternal Medicine, Shifa International Hospital, Islamabad, PAK.
Shahan HaseebInternal Medicine, Shifa International Hospital, Islamabad, PAK.
Mohammad W BaigShifa Clinical Skills and Informatics Laboratory, Shifa College of Medicine, Shifa Tameer-E-Millat University, Islamabad, PAK.
Palwasha QamarNeurosurgery, Shifa International Hospital, Islamabad, PAK.
Hamza H BangashObstetrics and Gynaecology, Hasan Medical & Surgical Complex, Hasan Abdal, PAK.
Zahra B ManzoorObstetrics and Gynaecology, Hasan Medical & Surgical Complex, Hasan Abdal, PAK.
Haider Ali Babar KhanInternal Medicine, Shifa International Hospital, Islamabad, PAK.
Misbah KaleemOtolaryngology, Shifa College of Medicine, Shifa Tameer-E-Millat University, Islamabad, PAK.
Shafia MunirInternal Medicine, Shifa International Hospital, Islamabad, PAK.
Shawal HaseebMedicine, Rawalpindi Medical University, Rawalpindi, PAK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myxomatous liposarcoma is an extremely rare type of mediastinal tumour that manifests in a manner comparable to other lung pathologies. Chest pain, shortness of breath, and dysphagia are the common presenting complaints. Radiological examinations or postoperative histological examinations provide the majority of the diagnostic evidence. The cornerstone of therapy consists of surgery and sometimes chemotherapy. Those who are afflicted have a better chance of experiencing favourable outcomes if they receive a diagnosis and treatment quickly.

Indexed as

mediastinal liposarcomamediastinummyxomatous liposarcomaotolaryngologyradiotherapy

Identifiers

PMID36176865
PMCPMC9512315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.